Development of diclofenac sodium controlled release solid dispersion powders and capsules by freeze drying technique using ethylcellulose and chitosan as carriers

被引:21
作者
Dangprasirt, P [1 ]
Pongwai, S [1 ]
机构
[1] Rangsit Univ, Fac Pharm, Patumtani 12000, Thailand
关键词
D O I
10.3109/03639049809097274
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Controlled-release, solid dispersions of diclofenac sodium (DS) were prepared by freeze-drying technique, using ethylcellulose (EC) and chitosan (CS) as single and combined carriers. Factorial design was applied as an experimental design to study the main and interactive effects of EC and CS on drug dissolution from the controlled release solid dispersion. All DS solid dispersions showed slower drug dissolution than did DS powder. The equations of dissolution parameters as functions of EC and CS contents were established through multiple regression. The contour plots of the established equations were constructed. The 10:(2.4 + 0.05) DS:(EC + CS) solid dispersion was prepared and developed into a capsule dosage from, using lactose as diluent. The effect on capsule dissolution of a disintegrant, sodium starch glycolate (Explotab(R)), in concentrations of 2%, 5%, and 8% was studied. The solid-dispersion capsule containing 5% Explotab was found to provide the most similar dissolution profile to the one obtained with the 10:(2.4 + 0.05) DS:(EC + CS) solid-dispersion powder. The dissolutions of the 10:(2.4 + 0.05) solid-dispersion powder and capsules were closer to a first-order model than to a zero-order or diffusion control model.
引用
收藏
页码:947 / 953
页数:7
相关论文
共 12 条
[1]
[Anonymous], 1989, MARTINDALE EXTRA PHA
[2]
Christian MA., 1990, ANAL PROFILES DRUG S, P123
[3]
[4]
DANGPRASIRT P, 1996, THAI J PHARM SCI, V20, P185
[5]
DANGPRASIRT P, 1995, DRUG DEV IND PHARM, V21, P2333
[6]
DANGPRASIRT P, IN PRESS DRUG DEV IN
[7]
DUKKURI A, 1978, J PHARM SCI, V67, P354
[8]
SOLID DISPERSION CONTROLLED RELEASE - EFFECT OF PARTICLE-SIZE, COMPRESSION FORCE AND TEMPERATURE [J].
FASSIHI, AR ;
PARKER, MS ;
POURKAVOOS, N .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1985, 11 (2-3) :523-535
[9]
FORD JL, 1986, PHARM ACTA HELV, V61, P69
[10]
Rinaudo M., 1989, Chitin and chitosan: sources, chemistry, biochemistry, physical properties and applications, P71